罗莫苏祖马布用于治疗骨质疏松症 - - 一项系统性审查
V-N Mäkinen1, A S Sølling2, M McClung3
1Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. vivmaa@rm.dk.
Journal of endocrinological investigation
|November 2, 2024
概括
罗莫苏祖马布通过增加骨矿物质密度 (BMD) 和降低骨折风险,有效治疗骨质疏松症. 虽然通常是安全的,但需要进一步的研究来确认心血管安全性,特别是在二次性骨质疏松症患者.
科学领域:
- 内分泌学和新陈代谢学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨质疏松症是一个严重的健康问题,其特点是骨质较低,骨折风险增加.
- 作为一种胆固醇抑制剂的罗莫苏祖马布具有双重的作用机制:刺激骨形成和抑制其再吸收.
- 本综述评估了romosozumab对初级和二级骨质疏松症的疗效和安全性.
研究的目的:
- 系统地审查romosozumab在治疗骨质疏松症中的临床疗效.
- 评估romosozumab在不同患者群体中的安全性.
- 评估罗莫苏祖马布对骨矿物质密度 (BMD) 和骨折结果的影响.
主要方法:
- 在2023年10月之前对Embase,PubMed和Cochrane图书馆进行全面的文献搜索.
- 包括随机对照试验 (RCT) 和观察性研究.
- 根据PRISMA指南进行数据提取和质量评估.
主要成果:
- 与对照组相比,romosozumab在原发性骨质疏松症患者的多个部位显著增加了BMD.
- 连续治疗罗莫苏祖马布,其次是抗吸收药物,证明持续增加BMD,降低骨折风险.
- 罗莫苏祖马布一般耐受性良好,尽管心血管不良事件需要进一步调查.
结论:
- 罗莫苏祖马布作为高风险骨质疏松症患者的初始治疗有效,增加骨质量和减少骨折.
- 序列疗法优化了长期益处,心血管安全需要持续评估.
- 需要进一步的研究来确认二次性骨质疏松症的疗效和安全性.
相关概念视频
01:31Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
01:40Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
01:29Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K